HPLC Determination and Pharmacokinetic Study of Valdecoxib in Human Plasma

Practical HPLC Method Development

Analytical Chemistry · 1993 · 1.4K citations

Business, Pharmaceutical Analysis, Norm-referenced Assessment +5

Design and Analysis of Bioavailability and Bioequivalence Studies

Eric R. Ziegel, Shein Chung Chow, Jiewen Liu · Technometrics · 1994 · 492 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +12

Determination of candesartan cilexetil, candesartan and a metabolite in human plasma and urine by liquid chromatography and fluorometric detection

Helene Stenhoff, Per-Olof Lagerström, Cathrine Andersen · Journal of Chromatography B Biomedical Sciences and Applications · 1999 · 50 citations

Pharmacy, Pharmacokinetics, Pharmacology +8

Characterization of Conjugated Metabolites of a New Angiotensin II Receptor Antagonist, Candesartan Cilexetil, in Rats by Liquid Chromatography/Electrospray Tandem Mass Spectrometry Following Chemical Derivatization

Takahiro Kondo, Kiyoshi Yoshida, Yoshinobu Yoshimura et al. · Journal of Mass Spectrometry · 1996 · 48 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Development and validation of an automated SPE-LC-MS/MS assay for valdecoxib and its hydroxylated metabolite in human plasma

Ji Y. Zhang, Douglas M. Fast, Alan P. Breau · Journal of Pharmaceutical and Biomedical Analysis · 2003 · 21 citations

Life Sciences, Pharmaceutical Analysis, Pharmacology +12